Moreover, blood UCA1 levels are upregulated in patients with metastatic BC after cisplatin treatment, increasing WNT6 protein expression and activating Wnt signalling, which results in cisplatin resistance [160]. This evidence concerns the gene UCA1 and breast cancer.